Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Anthony Cerulli, Ph.D., M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F30CA220678 (CERULLI, ROBERT ANTHONY) Jul 1, 2017 - Jun 30, 2021
    Phosphotyrosine-mimicking peptides for the inhibition of the Src Homology 2 (SH2) Domain of the Signal Transducer and Activator of Transcription 3 (STAT3)
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Pace JR, Lampkin BJ, Abakah C, Moyer A, Miao J, Deprey K, Cerulli RA, Lin YS, Baleja JD, Baker D, Kritzer JA. Stapled ß-Hairpins Featuring 4-Mercaptoproline. J Am Chem Soc. 2021 09 22; 143(37):15039-15044. PMID: 34516087; PMCID: PMC9250296.
    Citations: 1     Fields:    Translation:Cells
  2. Cerulli RA, Shehaj L, Brown H, Pace J, Mei Y, Kritzer JA. Stapled Peptide Inhibitors of Autophagy Adapter LC3B. Chembiochem. 2020 10 01; 21(19):2777-2785. PMID: 32406996; PMCID: PMC7872222.
    Citations: 4     Fields:    Translation:HumansCells
  3. Cerulli RA, Shehaj L, Tosic I, Jiang K, Wang J, Frank DA, Kritzer JA. Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors. Bioorg Med Chem. 2020 06 15; 28(12):115542. PMID: 32503696.
    Citations: 4     Fields:    Translation:HumansCells
  4. Cerulli RA, Kritzer JA. Phosphotyrosine isosteres: past, present and future. Org Biomol Chem. 2020 01 28; 18(4):583-605. PMID: 31777907; PMCID: PMC7233463.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  5. Cerulli RA, Kritzer JA. Stringing Together a Universal Influenza Antibody. Biochemistry. 2019 04 16; 58(15):1943-1944. PMID: 30946571; PMCID: PMC6497390.
    Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  6. Liu S, Walker SR, Nelson EA, Cerulli R, Xiang M, Toniolo PA, Qi J, Stone RM, Wadleigh M, Bradner JE, Frank DA. Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. Mol Cancer Ther. 2014 May; 13(5):1194-205. PMID: 24435449; PMCID: PMC4013223.
    Citations: 41     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cerulli's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (48)
Co-Authors (4)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.